Cargando…

Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series

BACKGROUND: Corona Virus Disease 2019 (COVID-19) pneumonitis associated with severe respiratory failure carries a high mortality. Coagulopathy has emerged as a significant contributor to thrombotic complications. CASE SUMMARY: We describe two cases of severe COVID-19 pneumonitis refractory to conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro-Verdes, Mireya, Gkouma, Antonia, Wort, John, Ridge, Carole, Mirsadraee, Saeed, Padley, Simon, Sheikh, Awais, Singh, Suveer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793039/
https://www.ncbi.nlm.nih.gov/pubmed/33442596
http://dx.doi.org/10.1093/ehjcr/ytaa470
Descripción
Sumario:BACKGROUND: Corona Virus Disease 2019 (COVID-19) pneumonitis associated with severe respiratory failure carries a high mortality. Coagulopathy has emerged as a significant contributor to thrombotic complications. CASE SUMMARY: We describe two cases of severe COVID-19 pneumonitis refractory to conventional mechanical ventilation and proning position, transferred to our specialist centre for cardiorespiratory failure. Cross-sectional imaging demonstrated concurrent venous and aortic thrombosis with end-organ ischaemic changes. One patient received thrombolysis with a partial response. This could not be offered to the other patient due to a recent haemorrhagic event. Both patients died of multi-organ failure in the hospital. DISCUSSION: Concurrent aortic and venous thromboses are rare. This finding in COVID-19 cases, who were both critically ill patients, likely reflects the strongly thrombogenic nature of this illness which ultimately contributed to poor outcomes. The absence of deep vein thrombosis or a potential systemic source of embolism suggests in situ thrombosis. Further, the management of anticoagulation and thrombolysis is challenging in patients where an attendant bleeding risk exists.